Chemistry and biology of salicylihalamide A and related compounds

Chemical Reviews

Volumn 103, Issue 11, 2003, Pages 4283-4306

  Yet, Larry ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOBATAMIDE ANALOGUES; MACROLACTONIZATION; NICOLAOU SYNTHESIS; PORCO SYNTHESIS; RING CLOSING METHATHESIS; SALICYLIHALAMIDE; STILLE COUPLING; SUZUKI COUPLING APPROACH; TAYLOR FORMAL SYNTHESIS;

BIOSYNTHESIS; CATALYSIS; CELL CULTURE; DISEASES; DRUG PRODUCTS; MOLECULAR STRUCTURE; ONCOLOGY; REACTION KINETICS; TUMORS;

AMINES;

ANTINEOPLASTIC AGENT; FUSED HETEROCYCLIC RINGS; SALICYLIHALAMIDE A;

CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; IC 50; REVIEW; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0345134728     PISSN: 00092665     EISSN: None     Source Type: Journal    
DOI: 10.1021/cr030035s     Document Type: Article

References (101)

1. For reviews on the influence of natural products isolation upon drug discovery, see: (a) Newmann, D. J.; Cragg, G. M.; Snader, K. M. Nat. Prod. Rep. 2000, 17, 215.
2. (b) Kingston, D. G.; Newman, D. J. Curr. Opin. Drug Discuss. Dev. 2002, 5, 304.
3. (c) Breinbauer, R.; Vetter, I. R.; Waldmann, H. Angew. Chem., Int. Ed. 2002, 41, 2879.
4. For recent reviews on solution-and solid-phase strategies toward the synthesis of libraries based on natural product templates, and syntheses of natural product-like libraries, see: (a) Hall, D. G.; Manku, S.; Wang, F. J. Comb. Chem. 2001, 3, 125.
5. (b) Arya, P.; Joseph, R.; Chou, D. T. H. Chem. Biol. 2002, 9, 145.
6. (c) Arya, P.; Baek, M.-G. Curr. Opin. Chem. Biol. 2001, 5, 292.
7. (d) Breinbauer, R.; Manger, M.; Scheck, M.; Waldmann, H. Curr. Med. Chem. 2002, 9, 2129.
8. For comprehensive surveys of combinatorial library synthesis, see: (a) Dolle, R. E. Mol. Diversity 1998, 3, 199.
9. (b) Dolle, R. E. J. Comb. Chem. 1999, 1, 235.
10. (c) Dolle, R. E. J. Comb. Chem. 2000, 2, 383.
11. (d) Dolle, R. E. J. Comb. Chem. 2001, 3, 477.
12. (e) Dolle, R. E. J. Comb. Chem. 2002, 4, 369.
13. (f) Bhattacharyya, S. Curr. Med. Chem. 2001, 8, 1383.
14. Grifo, F.; Newman, D.; Fairfield, A. S.; Bhattaharya, B.; Grupenhoff, J. T. The Origins of Prescription Drugs. In Biodiversity and Human Health; Grifo, F., Rosenthal, J., Eds.; Island Press: Washington, DC, 1997; p 131.
15. Erickson, K. L.; Beutler, J. A.; Cardellina, J. H., II; Boyd, M. R. J. Org. Chem. 1997, 62, 8188.
16. Erickson, K. L.; Beutler, J. A.; Cardellina, J. H., II; Boyd, M. R. J. Org. Chem. 2001, 66, 1532.
17. (a) Kunze, B.; Jansen, R.; Sasse, F.; Höfle, G.; Reichenbach, H. J. Antibiot. 1998, 51, 1075.
18. (b) Jansen, R.; Kunze, B.; Reinchenbach, H.; Höfle, G. Eur. J. Org. Chem. 2000, 913.
19. McKee, T. C.; Galinis, D. L.; Pannell, L. K.; Cardellina, J. H., II.; Laakso, J.; Ireland, C. M.; Murray, L.; Capon, R. J.; Boyd, M. R. J. Org. Chem. 1998, 63, 7805.
20. Dekker, K. A.; Aiello, R. J.; Hirai, H.; Inagaki, T.; Sakakibara, T.; Suzuki, Y.; Thompson, J. F.; Yamauchi, Y.; Kojima, N. J. Antibiot. 1998, 51, 14.
21. Kim, J. W.; Shin-ya, K.; Furihata, K.; Hayakawa, Y.; Seto, H. J. Org. Chem. 1999, 64, 153.
22. Isolation and structure of zearalenome: (a) Stob, M.; Baldwin, R. S.; Tuite, J.; Andrews, F. N.; Gillette, K. G. Nature 1962, 196, 1318.
23. (b) Urry, W. H.; Wehmeister, H. L.; Hodge, E. B.; Hidy, P. H. Tetrahedron Lett. 1966, 3109.
24. (c) Cordier, C.; Gruselle, M.; Jaouen, G.; Hughes, D. W.; McGlinchey, M. J. Magn. Reson. Chem. 1990, 28, 835.
25. Previous syntheses of zearalenome: Fürstner, A.; Thiel, O. R.; Kindler, N.; Bartkowska, B. J. Org. Chem. 2000, 65, 7990 and references therein.
26. Isolation and structure of radicicol and monocillin: (a) Delmotte, P.; Delmotte-Plaquée, J. Nature 1953, 171, 344.
27. (b) Ayer, W. A.; Lee, S. P.; Tsuneda, A.; Hiratsuka, Y. Can. J. Microbiol. 1980, 26, 766.
28. (c) Cutler, H. G.; Arrendale, R. F.; Springer, J. P.; Cole, P. D.; Roberts, R. G.; Hanlin, R. T. Agric. Biol. Chem. 1987, 51, 3331.
29. Previous syntheses of radicicol and monocillin: (a) Lampilas, M.; Lett, R. Tetrahedron Lett. 1992, 33, 773, 777.
30. (b) Garbaccio, R. M.; Stachel, S. J.; Baeschilin, D. K.; Danishefsky, S. J. J. Am. Chem. Soc. 2001, 123, 10903.
31. Roe, S. M.; Prodromou, C.; O'Brien, R.; Ladbury, J. E.; Piper, P. W.; Pearl, L. H. J. Med. Chem. 1999, 42, 260.
32. For reviews on the ring-closing metathesis reaction, see: (a) Grubbs, R. H.; Pine, S. H. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon: New York, 1991; Vol. 5, Chapter 9.
33. (b) Schmalz, H.-G. Angew. Chem., Int. Ed. 1995, 34, 1833.
34. (c) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. 1997, 36, 2036.
35. (d) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413.
36. Armstrong, S. A. J. Chem. Soc., Perkin Trans. 1 1998, 371.
37. (f) Randall, M. L.; Snapper, M. L. J. Mol. Catal. A: Chem. 1998, 133, 29.
38. (g) Pariya, C.; Jayaprakash, K. N.; Sarkar, A. Coord. Chem. Rev. 1998, 168, 1.
39. (h) Phillips, A. J.; Abell, A. D. Aldrichim. Acta 1999, 32, 75.
40. (i) Wright, D. L. Curr. Org. Chem. 1999, 3, 211.
41. (j) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3013.
42. (k) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18.
43. Fürstner, A.; Thiel, O. R.; Blanda, G. Org. Lett. 2000, 2, 3731.
44. Fürstner, A.; Dierkes, T.; Thiel, O. R.; Blanda, G. Chem. Eur. J. 2001, 5286.
45. Snider, B. B.; Song, F. Org. Lett. 2001, 3, 1817.
46. (a) Wu, J.; Liao, X.; Wang, R.; Xie, X.-S.; De Brabander, J. K. J. Am. Chem. Soc. 2002, 124, 3245.
47. (b) Wu, Y.; Esser, L.; De Brabander, J. K. Angew. Chem., Int. Ed. 2000, 39, 4308.
48. (c) Bhattacharjee, A.; De Brabander, J. K. Tetrahedron Lett. 2000, 41, 8069.
49. Labrecque, D.; Charron, S.; Rej, R.; Blais, C.; Lamothe, S. Tetrahedron Lett. 2001, 42, 2645.
50. Georg, G. I.; Ahn, Y. M.; Blackman, B.; Farokhi, F.; Flaherty, P. T.; Mossman, C. J.; Roy, S.; Yang, K. J. Chem. Soc., Chem. Commun. 2001, 255.
51. (a) De Silva, S. O.; Reed, J. N.; Billedeau, R. J.; Wang, X.; Norris, D. J.; Snieckus, V. Tetrahedron 1992, 48, 4863.
52. (b) Bibi, M. P.; Miah, M. A. J.; Snieckus, V. J. Org. Chem. 1984, 49, 737.
53. (a) Smith, A. B., III; Zheng, J. Tetrahedron 2002, 58, 6455.
54. (b) Smith, A. B., III; Zheng, J. Synlett 2001, 1019.
55. Masamune, S.; Ma, P.; Okumoto, H.; Ellingobe, J. W.; Ito, Y. J. Org. Chem. 1984, 49, 2837.
56. Kermadec, K.; Prudhomme, M. Tetrahedron Lett. 1993, 34, 2757.
57. Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L. J. Am. Chem. Soc. 1997, 119, 6496.
58. (a) Lee, A. W. M.; Chan, W. H.; Wong, H. C.; Wong, M. S. Synth. Commun. 1989, 19, 547.
59. (b) Patroni, J. J.; Stick, R. V. Aust. J. Chem. 1978, 31, 445.
60. (c) Iacono, I.; Rasmussen, J. R.; Card, J.; Smart, B. E. Organic Syntheses; Wiley & Sons: New York, 1993; Collect. Vol. VII, p 139.
61. For a selected example of reversible olefin metathesis reactions, see: Fürstner, A.; Thiel, O. R.; Ackermann, L. Org. Lett. 2001, 3, 449 and references therein.
62. (a) Sanford, M. S.; Love, J. A.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 6543.
63. (b) Ulman, M.; Grubbs, R. H. J. Org. Chem. 1999, 64, 7202.
64. Bauer, M.; Maier, M. E. Org. Lett. 2002, 4, 2205.
65. Duthaler, R. O.; Herold, P.; Lottenbach, W.; Oertle, K.; Riediker, M. Angew. Chem., Int. Ed. 1989, 28, 495.
66. Formal total synthesis: Holloway, G. A.; Hügel, H. M.; Rizzacasa, M. A. J. Org. Chem. 2003, 68, 2200.
67. Feutrill, T.; Holloway, G. A.; Hilli, F.; Hügel, H. M.; Rizzacasa, M. A. Tetrahedron Lett. 2000, 41, 8569.
68. Drouet, K. E.; Theodorakis, E. A. Chem. Eur. J. 2000, 6, 1987.
69. Bhattacharjee, A.; De Brabander, J. K. Tetrahedron Lett. 2000, 41, 8069.
70. Bhattacharjee, A.; Seguil, O. R.; De Brabander, J. K. Tetrahedron Lett. 2001, 42, 1217.
71. (a) Lewis, A.; Stefanuti, I.; Swain, S. A.; Smith, S. A.; Taylor, R. J. K. Tetrahedron Lett. 2001, 42, 5549.
72. (b) Lewis, A.; Stefanuti, I.; Swain, S. A.; Smith, S. A.; Taylor, R. J. K. Org. Biomol. Chem. 2003, 1, 104.
73. Nicolaou, K. C.; Kim, D. W.; Baati, R. Angew. Chem., Int. Ed. 2002, 41, 3701.
74. Hilli, F.; White, J. M.; Rizzacasa, M. A. Tetrahedron Lett. 2002, 43, 8507.
75. White, J. D.; Blakemore, P. R.; Browder, C. C.; Hong, J.; Lincoln, C. M.; Nagorny, P. A.; Robarge, L. A.; Wardrop, D. J. J. Am. Chem. Soc. 2001, 123, 8593.
76. Kuhnert, S. M.; Maier, M. E. Org. Lett. 2002, 4, 643.
77. Brunner, H.; Lautenschlager, H.-H. Synthesis 1989, 706.
78. (a) Shen, R.; Lin, C. T.; Porco, J. A., Jr. J. Am. Chem. Soc. 2002, 124, 5650.
79. (b) Shen, R.; Lin, C. T.; Bowman, E. J.; Bowman, B. J.; Porco, J. A., JR. J. Am. Chem. Soc. 2003, 125, 7889.
80. For synthetic studies to enamide side chains, see: (a) Snider, B. B.; Song, F. Org. Lett. 2000, 2, 407.
81. (b) Kuramochi, K.; Watanabe, H.; Kitahara, T. Synlett 2000, 397.
82. (c) Shen, R.; Porco, J. A., Jr. Org. Lett. 2000, 2, 1333.
83. (d) Stefanuti, I.; Smith, S. A.; Taylor, R. J. K. Tetrahedron Lett. 2000, 41, 3735.
84. (e) Fürstner, A.; Brehm, C.; Cancho-Grande, Y. Org. Lett. 2001, 3, 3955.
85. Coleman, R. S.; Garg, R. Org. Lett. 2001, 3, 3487.
86. Scheufler, F.; Maier, M. E. Synlett 2001, 1221.
87. Wang, X.; Porco, J. A., Jr. J. Am. Chem. Soc. 2003, 125, 6040.
88. (a) Boyd, M. R. In Cancer: Principles and Practice of Oncology Updates; DeVita, V. T., Hellman, S., Jr., Rosenberg, S. A., Eds.; Lippincott: Philadelphia, 1989; Vol. 3, No. 10, pp 1-12.
89. (b) Boyd, M. R. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approvals; Teicher, B., Ed.; Humana Press: Towata, NY, 1997; pp 23-42.
90. (c) Boyd, M. R.; Paull, K. Drug. Dev. Res. 1995, 34, 91.
91. (d) Weinstein, J. N.; Myers, T. G.; O'Connor, P. M.; Friend, S. H.; Fornace, A. J., Jr.; Kohn, K.; Fojo, T.; Bates, S. E.; Rubinstein, L. V.; Anderson, N. L.; Boulamwini, J. K.; van Osdol, W.; Monks, A. P.; Scudiero, D. A.; Sausville, E. A.; Zaharevitz, D. W.; Bunow, B.; Viswanadan, V. N.; Johnson, G. W.; Wittes, R. E.; Paull, K. D. Science 1997, 275, 343.
92. Boyd, M. R.; Farina, C.; Belfiore, P.; Gagliardi, S.; Kim, J. W.; Hayakawa, Y.; Beutler, J. A.; McKee, T. C.; Bowman, B. J.; Bowman, E. J. J. Pharmacol. Exp. Ther. 2001, 297, 114.
93. For reviews on V-ATPases, see: (a) Forgac, M. Adv. Mol. Cell. Biol. 1998, 23B, 403.
94. (b) Farina, C.; Gagliardi, S. Drug Discovery Today 1999, 4, 163.
95. (c) Keeling, D. J.; Herslof, M.; Ryberg, B.; Sjogren, S.; Solvell, I. Ann. N.Y. Acad. Sci. 1997, 834, 600.
96. (d) Nishi, T.; Forgac, M. Nat. Rev. Mol. Cell Biol. 2002, 3, 94.
97. (e) Beutler, J. A.; McKee, T. C. Curr. Med. Chem. 2003, 10, 789.
98. (a) Bowman, E. J.; Seibers, A.; Altendorf, K. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 7972.
99. (b) Dröse, S.; Altendorf, K. J. Exp. Biol. 1997, 200, 1.
100. Wu, Y.; Seguil, O. R.; De Brabander, J. K. Org. Lett. 2000, 2, 4241.
101. Shen, R.; Lin, C. T.; Bowman, E. J.; Bowman, B. J., Porco, J. A., Jr. Org. Lett. 2002, 4, 3103.